Restless legs syndrome: Differential diagnosis and management with rotigotine

Neuropsychiatric Disease and Treatment

Volumn 5, Issue 1, 2009, Pages 67-80

  Merlino, Giovanni ^a,c   Serafini, Anna ^a   Robiony, Francesca ^b   Valente, Mariarosaria ^a,c   Gigli, Gian Luigi ^a,c  

^a Sleep Disorder Center   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Diagnosis; Differential diagnosis; Dopamine agonists; Restless legs syndrome; Rotigotine

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; PLACEBO; ROTIGOTINE;

AKATHISIA; ANAMNESIS; CLAUDICATION; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG INDUCED HEADACHE; DRUG METABOLISM; DRUG SAFETY; DRUG SELECTIVITY; DRUG TOLERABILITY; FATIGUE; FIRST PASS EFFECT; FOOD AND DRUG ADMINISTRATION; GERIATRICS; HUMAN; HYPERHIDROSIS; INSOMNIA; KIDNEY FAILURE; LEG CRAMP; LEG PAIN; LIVER FAILURE; MERALGIA PARESTHETICA; MOTOR DYSFUNCTION; MYOCLONUS; NAUSEA; NEUROLOGIC EXAMINATION; NOTE; PEDIATRICS; PERIPHERAL NEUROPATHY; PHARMACODYNAMICS; PHYSICAL EXAMINATION; PREGNANT WOMAN; PREVALENCE; PRIMARY HEALTH CARE; PRURITUS; RADICULOPATHY; RESTLESS LEGS SYNDROME; SINGLE DRUG DOSE; SLEEP DISORDER; SPINAL CORD DISEASE; SYMPTOMATOLOGY; VEIN DISEASE;

EID: 70449724714     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: None     Document Type: Note

References (100)

1. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 2nd edition (ICSD-2): Diagnostic and coding manual. American Academy of Sleep Medicine, Westchester, IL; 2005.
2. Allen RP, Picchietti D, Hening WA, et al; Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health in collaboration with members of the International Restless Legs Syndrome Study Group. Restless Legs Syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101-119.
3. Qu S, Ondo WG, Zhang X, Xie WJ, Pan TH, Le WD. Projections of diencephalic dopamine neurones into the spinal cord in mice. Exp Brain Res. 2006;168(1-2):152-156. (Pubitemid 41752820)
4. Jensen TS, Smith DF. Dopaminergic effects on tail-flick response in spinal rats. Eur J Pharmacol. 1982;79(1-2):129-133.
5. Ondo WG, He Y, Rajasekaran S, Le WD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord. 2000;15(1):154-158. (Pubitemid 30038003)
6. Qu S, Le W, Zhang X, Xie W, Zhang A, Ondo WG. Locomotion is increased in A11 lesioned mice with iron deprivation: a possible animal model for restless legs syndrome. J Neuropath Exp Neurol. 2007;66(5):383-388. (Pubitemid 46701320)
7. Youdim M, Yehuda S. Iron deficiency induces reversal of dopamine dependent circadian cycles: differential response to d-amphetamine and TRH. Peptides. 1985;6(5):851-855. (Pubitemid 16170971)
8. Dean T Jr, Allen RP, O'Donnell C P, Earley CJ. The effects of dietary iron deprivation on murine circadian sleep architecture. Sleep Med. 2006;7(8):634-640.
9. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61(3):304-309.
10. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56(2):263-265. (Pubitemid 32095374)
11. Earley CJ, Hyland K, Allen RP. Circadian changes in CSF dopaminergic measures in restless legs syndrome. Sleep Med. 2006;7(3):263-268.
12. Schmidauer C, Sojer M, Seppi K, et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol. 2005;58(4):630-634. (Pubitemid 41377229)
13. Godau J, Schweitzer KJ, Liepelt I, Gerloff C, Berg D. Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome. Mov Disord. 2007;22(2):187-192. (Pubitemid 46374759)
14. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord. 2007;22(Suppl 18):S440-448.
15. Winkelmann J, Wetter TC, Collado-Seidel V, et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep. 2000;23(5):597-602. (Pubitemid 30636654)
16. Winkelmann J. Genetics of restless legs syndrome. Curr Neurol Neurosci Rep. 2008;8(3):211-216.
17. Desautels A, Turecki G, Montplaisir J, et al. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet. 2001;69(6):1266-1270. (Pubitemid 33124208)
18. Desautels A, Turecki G, Montplaisir J, et al. Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity. Arch Neurol. 2005;62(4):591-596. (Pubitemid 40489891)
19. Winkelmann J, Lichtner P, Putz B, et al. Evidence for further genetic locus heterogeneity and confirmation of RLS-1 in restless legs syndrome. Mov Disord. 2006;21(1):28-33. (Pubitemid 43273746)
20. Bonati MT, Ferini-Strambi L, Aridon P, et al. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain. 2003;126(6):1485-1492. (Pubitemid 36644391)
21. Levchenko A, Montplaisir JY, Dube MP, et al. The 14q restless legs syndrome locus in the French Canadian population. Ann Neurol. 2004;55(6):887-891. (Pubitemid 38702587)
22. Chen S, Ondo WG, Rao S, et al. Genome-wide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet. 2004;74(5):876-885. (Pubitemid 38568962)
23. Liebetanz KM, Winkelmann J, Trenkwalder C, et al. RLS3: fine-mapping of an autosomal dominant locus in a family with intrafamilial heterogeneity. Neurology. 2006;67(2):320-321. (Pubitemid 44305424)
24. Lohmann-Hedrich K, Neumann A, Kleensang A, et al. Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci? Neurology. 2008;70(9):686-694.
25. Pichler I, Marroni F, Volpato CB, et al. Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate. Am J Hum Genet. 2006;79(4):716-723. (Pubitemid 44452749)
26. Levchenko A, Provost S, Montplaisir JY, et al. A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13. Neurology. 2006;67(5):900-901. (Pubitemid 44394216)
27. Kemlink D, Plazzi G, Vetrugno R, et al. Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. Neurogenetics. 2008;9(2):75-82.
28. Winkelmann J, Lichtner P, Kemlink D, et al. New loci for restless legs syndrome map to chromosome 4q and 17p [abstract]. Mov Disord. 2006, P304.
29. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifi es common variants in three genomic regions. Nat Genet. 2007;39(8):1000-1006. (Pubitemid 47185185)
30. Stefansson H, Rye DB, Hicks A, et al. Genetic risk factor for periodic limb movements in sleep. N Engl J Med. 2007;357(7):639-647. (Pubitemid 47267233)
31. Schormair B, Kemlink D, Roeske D, et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet. 2008;40(8):946-948.
32. Merlino G, Valente M, Serafi ni A, Gigli GL. Restless legs syndrome: diagnosis, epidemiology, classifi cation and consequences. Neurol Sci. 2007;28(Suppl 1):S37-46. (Pubitemid 46152127)
33. Merlino G, Fratticci L, Valente M, et al. Association of restless legs syndrome in type 2 diabetes: a case-control study. Sleep. 2007;30(7):866-871. (Pubitemid 47044818)
34. Manconi M, Ferini-Strambi L, Filippi M, et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis: The REMS study. Sleep. 2008;31(7):944-952. (Pubitemid 351956933)
35. Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis. 2004;43(4):663-670. (Pubitemid 38401881)
36. Nordlander NB. Therapy in restless legs. Acta Med Scand. 1953;145(6):453-457.
37. Earley CJ, Heckler D, Allen RP. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med. 2004;5(3):231-235. (Pubitemid 38684216)
38. Earley CJ, Horská A, Mohamed MA, Barker PB, Beard JL, Allen RP. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med. 2008. in press.
39. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005;165(11):1286-1292. (Pubitemid 40989594)
40. Kushida C, Martin M, Nikam P, et al. Burden of restless legs syndrome on health-related quality of life. Qual Life Res. 2007;16(4):617-624. (Pubitemid 46474940)
41. Winkelmann J, Prager M, Lieb R, et al. "Anxietas tibiarum." Depression and anxiety disorders in patients with restless legs syndrome. J Neurol. 2005;252(1):67-71. (Pubitemid 40179020)
42. Pearson VE, Allen RP, Dean T, Gamaldo CE, Lesage SR, Earley CJ. Cognitive defi cits associated with restless legs syndrome (RLS). Sleep Med. 2006;7(1):25-30. (Pubitemid 43033541)
43. Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology. 2008;70(1):35-42.
44. Happe S, Vennemann M, Evers S, Berger K. Treatment wish of individuals with know and unknown restless legs syndrome in the community. J Neurol. 2008;255(9):1365-1371.
45. Chesson Al Jr, Wise M, Davila D, et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 1999;22(8):961-968.
46. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine review. Sleep. 1999;22(7):970-999.
47. Littner MR, Kushida C, Anderson WM, et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004;27(3):557-559. (Pubitemid 44138821)
48. Hening WA, Allen RP, Earley CJ, Picchietti DL, Silber MH. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004;27(3):560-583. (Pubitemid 44138822)
49. Vignatelli L, Billard M, Clarenbach P, et al. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep; EFNS Task Force. Eur J Neurol. 2006;13(10):1049-1065. (Pubitemid 44434310)
50. Oertel WH, Trenkwalder C, Zucconi M, et al. State of the art in restless legs syndrome therapy: Practice recommendations for treating restless legs syndrome. Mov Disord. 2007;22(Suppl 18):S466-475.
51. Trenkwalder C, Hening WA, Montagna P, et al. Treatment of restless legs syndrome: An evidence-based review and implications for clinical practice. Mov Disord. 2008. in press.
52. Zanetti R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med. 2007;356(1):39-46. (Pubitemid 46041752)
53. Schade R, Anderohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med. 2007;356(1):29-38. (Pubitemid 46041751)
54. Garcia-Borreguero D, Allen RP, Kohnen R et al; International Restless Legs Syndrome Study Group. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med. 2007;8(5):520-530. (Pubitemid 46972001)
55. Earley CJ, Allen RP. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep. 1996;19(10):801-810. (Pubitemid 27131931)
56. Trenkwalder C, Benes H, Grote L, et al; Caldir Study Group. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial. Mov Disord. 2007;22(5):696-703. (Pubitemid 46800141)
57. Horvath J, Landis T, Burkhard PR. Restless arms. Lancet. 20089;371(9611):530.
58. Buchfuhrer MJ. Restless legs syndrome (RLS) with expansion of symptoms to the face. Sleep Med. 2008;9(2):188-190.
59. Alisky JM. Restless arm symptoms as an extension of restless leg syndrome. Age Ageing. 2007;36(1):107. (Pubitemid 47072045)
60. Freedom T, Merchut MP. Arm restlessness as the initial symptom in restless legs syndrome. Arch Neurol. 2003;60(7):1013-1015. (Pubitemid 36858364)
61. Chabli A, Michaud M, Montplaisir J. Periodic arm movements in patients with the restless legs syndrome. Eur Neurol. 2000;44(3):133-138. (Pubitemid 30823570)
62. Michaud M, Chabli A, Lavigne G, Montplaisir J. Arm restlessness in patients with restless legs syndrome. Mov Disord. 2000;15(2):289-293. (Pubitemid 30166735)
63. Webb AT. Letter: Restless arms syndrome. JAMA. 1976;236(7):822.
64. Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology. 2006;67(1):125-130. (Pubitemid 44305475)
65. Montplaisir J, Boucher S, Nicolas A, et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord. 1998;13(2):324-349. (Pubitemid 28127810)
66. Michaud M, Lavigne G, Desautels A, et al. Effects of immobility on sensory and motor symptoms of restless legs syndrome. Mov Disord. 2002;17(1):112-115. (Pubitemid 36049998)
67. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lespérance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12(1):61-65. (Pubitemid 27032881)
68. American Sleep Disorders Association (ASDA) Atlas Task Force of the American Sleep Disorders Association. Recording and scoring leg movements. Sleep. 1993;16(8):748-759.
69. Carrier J, Frenette S, Montplaisir J, Paquet J, Drapeau C, Morettini J. Effects of periodic leg movements during sleep in middle-aged subjects without sleep complaints. Mov Disord. 2005;20(9):1127-1132. (Pubitemid 41632199)
70. Michaud M, Lavigne G, Desautels A, Poirier G, Montplaisir J. Effects of immobility on sensory and motor symptoms of restless legs syndrome. Mov Disord. 2002;17(1):112-115. (Pubitemid 36049998)
71. Hening WA, Walters AS, Wagner M, et al. Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep. 1999;22(7):901-912. (Pubitemid 29526510)
72. Michaud M, Dumont M, Selmaoui B, Paquet J, Fantini ML, Montplaisir J. Circadian rhythm of restless legs syndrome: relationship with biological markers. Ann Neurol. 2004;55(3):372-380. (Pubitemid 38269589)
73. Trenkwalder C, Hening WA, Walters AS, Campbell SS, Rahman K, Chokroverty S. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord. 1999;14(1):102-110. (Pubitemid 29224683)
74. Michaud M, Dumont M, Paquet J, Desautels A, Fantini ML, Montplaisir J. Circadian variation of the effects of immobility on symptoms of restless legs syndrome. Sleep. 2005;28(7):843-846. (Pubitemid 40993714)
75. Tribl GG, Waldhauser F, Sycha T, Auff E, Zeitlhofer J. Urinary 6-hydroxy-melatonin-sulfate excretion and circadian rhythm in patients with restless legs syndrome. J Pineal Res. 2003;35(4):295-296. (Pubitemid 37338865)
76. Wetter TC, Collado-Seidel V, Oertel H, Uhr M, Yassouridis A, Trenkwalder C. Endocrine rhythms in patients with restless legs syndrome. J Neurol. 2002;249(2):146-151. (Pubitemid 34143468)
77. Hening W. The clinical neurophysiology of the restless legs syndrome and periodic limb movements. Part I: diagnosis, assessment, and characterization. Clin Neurophysiol. 2004;115(9):1965-1974. (Pubitemid 39037285)
78. Baier PC, Trenkwalder C. Circadian variation in restless legs syndrome. Sleep Med. 2007;8(6):445-450. (Pubitemid 47181204)
79. Benes H, Walters AS, Allen RP, Hening WA, Kohnen R. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord. 2007;22(Suppl 18):S401-408.
80. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5(3):237-246. (Pubitemid 38684217)
81. Walters AS, Hening W, Rubistein M, Chokroverty S. A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome. Sleep. 1991;14(4):339-345.
82. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry. 2002;35(3):109-111. (Pubitemid 34651917)
83. Kraus T, Schuld A, Pollmächer T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol. 1999;19(5):478-479. (Pubitemid 29451517)
84. Duggal HS, Mendhekar DN. Clozapine-associated restless legs syndrome. J Clin Psychopharmacol. 2007;27(1):89-90.
85. Pinninti NR, Mago R, Townsend J, Doghramji K. Periodic restless legs syndrome associated with quetiapine use: a case report. J Clin Psychopharmacol. 2005;25(6):617-618. (Pubitemid 41669066)
86. Rutkove SB, Matheson JK, Logigian EL. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve. 1996(5);19:670-672. (Pubitemid 26120181)
87. Gemignani F, Marbini A. Restless legs syndrome and peripheral neuropathy. J Neurol Neurosurg Psychiatry. 2002;72(4):555. (Pubitemid 34289582)
88. Salvi F, Montagna P, Plasmati R, et al. Restless legs syndrome and nocturnal myoclonus: initial clinical manifestation of familial amyloid polyneuropathy. J Neurol Neurosurg Psychiatry. 1990;53(6):522-525. (Pubitemid 20189591)
89. Gemignani F, Marbini A, Di Giovanni G, et al. Cryoglobulinaemic neuropathy manifesting with restless legs syndrome. J Neurol Sci. 1997;152(2):218-223. (Pubitemid 27509191)
90. Iannaccone S, Zucconi M, Marchettini P, et al. Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord. 1995;10(1):2-9.
91. Gemignani F, Marbini A, Di Giovanni G, Salih S, Terzano MG. Charcot-Marie-Tooth disease type 2 with restless legs syndrome. Neurology. 1999;52(5):1064-1066. (Pubitemid 29161621)
92. Polydefkis M, Allen RP, Hauer P, Earley CJ, Griffin JW, McArthur JC. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology. 2000;55(8):1115-1121. (Pubitemid 30802989)
93. Gemignani F, Brindani F, Vitetta F, Marbini A, Calzetti S. Restless legs syndrome in diabetic neuropathy: a frequent manifestation of small fiber neuropathy. J Peripher Nerv Syst. 2007;12(1):50-53. (Pubitemid 46434535)
94. Stiasny-Kolster K, Kohnen R, Schollmayer E, Möller JC, Oertel WH; Rotigotine S 666 Study. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study. Mov Disord. 2004;19(12):1432-1438. (Pubitemid 40109482)
95. Oertel WH, Benes H, Garcia-Borreguero D, et al; Rotigotine SP 709 Study Group. Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Med. 2008;9(3):228-239.
96. Oertel WH, Benes H, Garcia-Borreguero D, et al; Rotigotine SP 710. One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome. Sleep Med. 2008 in press.
97. Trenkwalder C, Benes H, Poewe W, et al. SP790 Study Group. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2008;7(7):595-604.
98. Bassetti CL, Clavadetscher SC, Gugger M, Hess CW. Pergolide-associated "sleep attacks" in a patient with restless legs syndrome. Sleep Med. 2002;3(3):275-277. (Pubitemid 34679366)
99. Kohnen R, Allen RP, Benes H, et al. Assessment of restless legs syndrome- Methodological approaches for use in practice and clinical trials. Mov Disord. 2007;22(Suppl 18):S485-494.
100. Stiasny-Kolster K, Kohnen R, Möller JC, Trenkwalder C, Oertel WH. Validation of the "L-DOPA test" for diagnosis of restless legs syndrome. Mov Disord. 2006;21(9):1333-1339.